Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
1st Aug 20174:32 pmRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
28th Jul 20178:16 amRNSAdmission to AIM
28th Jul 20178:00 amRNSCancellation Harvey Nash Group PLC
3rd Jul 20172:24 pmRNSAcquisition of PAT Management AB
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20174:23 pmRNSDirector/PDMR Shareholding
29th Jun 20172:00 pmRNSSchedule 1 - Harvey Nash Group Plc
29th Jun 201712:49 pmRNSMove to AIM - Results of General Meeting
29th Jun 201712:49 pmRNSResults of Annual General Meeting
29th Jun 20177:00 amRNSAGM Statement
12th Jun 20177:00 amRNSBlock listing Interim Review
5th Jun 201712:35 pmRNSMove to AIM and notice of GM
2nd Jun 20175:26 pmRNSDirector/PDMR Shareholding
1st Jun 20177:00 amRNSTotal Voting Rights
31st May 20179:06 amRNSHolding(s) in Company
26th May 20174:57 pmRNSHolding(s) in Company
10th May 20175:07 pmRNSHolding(s) in Company
9th May 20174:00 pmRNSHolding(s) in Company
3rd May 20173:40 pmRNSHolding(s) in Company
3rd May 201711:30 amRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSTotal Voting Rights
28th Apr 20179:35 amRNSHolding(s) in Company
27th Apr 20177:00 amRNSDirectorate Change
27th Apr 20177:00 amRNSFinal Results
3rd Apr 201710:51 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
28th Mar 20175:01 pmRNSHolding(s) in Company
9th Mar 20177:00 amRNSAppointment of Group Finance Director
7th Mar 20175:04 pmRNSHolding(s) in Company
6th Mar 20175:21 pmRNSHolding(s) in Company
3rd Mar 20175:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20177:00 amRNSPre-close Trading Update and Notice of Results
1st Mar 20177:00 amRNSTotal Voting Rights
3rd Feb 201711:54 amRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTotal Voting Rights
26th Jan 20175:50 pmRNSHolding(s) in Company
4th Jan 20173:55 pmRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSTotal Voting Rights
12th Dec 20167:00 amRNSBlock listing Interim Review
1st Dec 20167:00 amRNSTotal Voting Rights
30th Nov 20162:37 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSChange of Adviser
1st Nov 20167:00 amRNSTotal Voting Rights
27th Oct 20165:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20167:00 amRNSTotal Voting Rights
30th Sep 20165:19 pmRNSDirector/PDMR Shareholding
29th Sep 20167:00 amRNSUnaudited Half-year Results
5th Sep 20167:00 amRNSNotice of Results
1st Sep 20164:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.